IMTX SCHEDULE 13D/A: SEC filing
An amendment to a Schedule 13D was
Filed with the SEC on · accession 0001193125-26-371236
IMTX filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Aug 27, 2026. An amendment to a Schedule 13D was filed regarding Immatics N.V., indicating a change in a major shareholder's ownership position or intentions. The stock moved -0.7% by the first close after the filing.
Summary of the filing
An amendment to a Schedule 13D was filed regarding Immatics N.V., indicating a change in a major shareholder's ownership position or intentions. The filing text provided contains only the EDGAR directory listing and no substantive details of the amendment.
Key details
How IMTX stock reacted
Close before
$9.43
Aug 26, 2026
First close after
-0.74%
$9.36
5 trading days
+0.74%
$9.50
Since filing
-32.56%
$6.36
✦ Ask GOAX AI about this filing — what it means for IMTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMTX?
Click hereFrequently asked questions
What did IMTX file with the SEC on Aug 27, 2026?
IMTX filed a SCHEDULE 13D/A (SEC filing). An amendment to a Schedule 13D was filed regarding Immatics N.V., indicating a change in a major shareholder's ownership position or intentions. The filing text provided contains only the EDGAR directory listing and no substantive details of the amendment.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did IMTX stock react to this filing?
IMTX closed at $9.43 before the filing and $9.36 on Aug 27, 2026 (-0.74%). Five trading days later: $9.50 (+0.74%).
Other IMTX SEC filings
- 6-K · Fda approvalOct 26, 2026
- 6-K · SEC filingOct 23, 2026
- 6-K · Secondary offeringAug 26, 2026
- 424B2 · Secondary offeringAug 25, 2026
- 6-K · SEC filingAug 18, 2026
- 6-K · SEC filingJun 18, 2026
- 6-K · SEC filingJun 2, 2026
- 6-K · Fda approvalJun 1, 2026
- 6-K · SEC filingMay 12, 2026
- 6-K · Fda approvalApr 21, 2026
Get alerts when IMTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days